During the pandemic and beyond, working from home as a radiologist can present clear work-life advantages.
Although a concept that seemed unfamiliar to many at the onset of the pandemic, working from home--especially in health care--is nothing new for radiologist Elizabeth Hawk, M.S., M.D., Ph.D., an assistant professor of radiology at Stanford University Medical School. Hawk, who is also Director of Innovation Engagement and a Matrix Pod President for Radiology Partners, has been working from home using teleradiology for years.
At RSNA 2021, Hawk led a panel discussion focused on flexible work arrangements and their impact on career advancement for women radiologists. Hawk, who is a mother of 3, told Diagnostic Imaging that a flexible work arrangement, whether it be working from home or on a personalized schedule, has clear positive effects on work-life balance and shouldn't be looked down upon as a disadvantage when it comes to professional advancement.
Diagnostic Imaging sat down with Hawk to learn more about how radiologists can incorporate more flexible work arrangements into their career plans. Watch below:
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
2 Commerce Drive
Cranbury, NJ 08512